180 related articles for article (PubMed ID: 8394274)
1. Tissue tolerance to pelvic intraarterial chemoembolization with cisplatin-lipiodol suspension.
Li J; Zhao YN; Miao ZJ; Zhu L; Wang ZM; Qin HY; Xi JH
Gynecol Oncol; 1993 Jul; 50(1):10-4. PubMed ID: 8394274
[TBL] [Abstract][Full Text] [Related]
2. [Tissue tolerance to pelvic intraarterial chemoembolization].
Li J
Zhonghua Fu Chan Ke Za Zhi; 1993 Jan; 28(1):41-3, 61. PubMed ID: 8389277
[TBL] [Abstract][Full Text] [Related]
3. Long-term follow-up of hepatic arterial chemoembolization with cisplatin suspended in iodized oil for hepatocellular carcinoma.
Maeda S; Shibata J; Fujiyama S; Tanaka M; Noumaru S; Sato K; Tomita K
Hepatogastroenterology; 2003; 50(51):809-13. PubMed ID: 12828090
[TBL] [Abstract][Full Text] [Related]
4. Effects of hepatic artery chemoembolization using cisplatin-lipiodol suspension with gelatin sponge particles on swine liver.
Sahara S; Tanihata H; Sato M; Kawai N; Takasaka I; Minamiguchi H; Nakai M; Sonomura T
J Vasc Interv Radiol; 2009 Oct; 20(10):1359-64. PubMed ID: 19695901
[TBL] [Abstract][Full Text] [Related]
5. Hypersensitivity reactions to transcatheter chemoembolization with cisplatin and Lipiodol suspension for unresectable hepatocellular carcinoma.
Kawaoka T; Aikata H; Katamura Y; Takaki S; Waki K; Hiramatsu A; Takahashi S; Hieda M; Kakizawa H; Chayama K
J Vasc Interv Radiol; 2010 Aug; 21(8):1219-25. PubMed ID: 20619676
[TBL] [Abstract][Full Text] [Related]
6. [Anticancer and side effect of arterial subsegmental chemoembolization using cisplatinum/pirarubicin lipiodol suspension (CTLS) for hepatocellular carcinoma].
Inoue H; Miyazono N; Kanetsuki I; Hori A; Tanaka D; Fukukura Y; Matsumoto Y; Nishida H; Ueno K; Nakajo M
Gan To Kagaku Ryoho; 1993 Oct; 20(13):1973-6. PubMed ID: 7692822
[TBL] [Abstract][Full Text] [Related]
7. [Effect of the portal vein injection of cisplatin and lipiodol on rat liver].
Ono Y; Yoshioka H; Kawakami A; Ishida O; Suzuki T
Gan To Kagaku Ryoho; 1989 Oct; 16(10):3429-34. PubMed ID: 2552932
[TBL] [Abstract][Full Text] [Related]
8. [Intra-arterial injection of cisplatin suspension in Lipiodol (LPS) in the treatment of hepatocellular carcinoma].
Fukushima S; Kishimoto S; Hayashi Y; Nakano M; Shibata J; Fujiyama S; Sato T
Gan To Kagaku Ryoho; 1989 Aug; 16(8 Pt 2):3062-5. PubMed ID: 2551247
[TBL] [Abstract][Full Text] [Related]
9. Suitable blending method of lipiodol-cisplatin in transcatheter arterial embolization for hepatocellular carcinoma: evaluation of sustained release and accumulation nature.
Takaki Y; Kaminou T; Shabana M; Ihaya T; Otsubo K; Ogawa T
Hepatogastroenterology; 2008; 55(81):202-6. PubMed ID: 18507107
[TBL] [Abstract][Full Text] [Related]
10. [Effect of intra-arterially injected cisplatinum and lipiodol on the rat liver].
Kawakami A; Ishida O; Suzuki T
Gan To Kagaku Ryoho; 1988 Sep; 15(9):2787-92. PubMed ID: 2843134
[TBL] [Abstract][Full Text] [Related]
11. Prospective randomized trial of chemoembolization versus intra-arterial injection of 131I-labeled-iodized oil in the treatment of hepatocellular carcinoma.
Raoul JL; Guyader D; Bretagne JF; Heautot JF; Duvauferrier R; Bourguet P; Bekhechi D; Deugnier YM; Gosselin M
Hepatology; 1997 Nov; 26(5):1156-61. PubMed ID: 9362356
[TBL] [Abstract][Full Text] [Related]
12. [Plasma platinum concentration and anti-tumor effects after intra-arterial infusion of lipiodol-CDDP suspension evaluation with VX 2 rabbit liver cancer model and 7.0 Tesla MRI system].
Sonoda A; Nitta N; Ohta S; Itoh R; Takahashi M; Murata K; Morikawa S; Inubushi T; Miyagawa Y; Takamori M; Oonaka Y
Gan To Kagaku Ryoho; 2006 Jul; 33(7):951-7. PubMed ID: 16835486
[TBL] [Abstract][Full Text] [Related]
13. [Evaluation of the intra-hepatic arterial injection therapy of cisplatin (CDDP)-lipiodol suspension in a child with hepatoblastoma].
Ohtsubo K; Mitsuishi T; Higuchi S; Aoyama T; Sue K; Nakagawara A; Ikeda K
Nihon Gan Chiryo Gakkai Shi; 1990 Jan; 25(1):31-9. PubMed ID: 2157781
[TBL] [Abstract][Full Text] [Related]
14. [Efficacy and toxicity of transcatheter arterial chemoembolization with Cisplatin suspended in lipiodol for unresectable hepatocellular carcinoma].
Uyama N; Hatano E; Maetani Y; Isoda H; Shibata T; Taura K; Oe S; Naito M; Yasuchika K; Fujii H; Ikai I; Uemoto S
Gan To Kagaku Ryoho; 2008 May; 35(5):775-80. PubMed ID: 18487912
[TBL] [Abstract][Full Text] [Related]
15. [Intraarterial injection therapy of CDDP-PC-lipiodol suspension for hepatoma].
Aikawa H; Mori H; Hirao K; Ajimu A; Iwao M; Hayashi K; Hombo Z; Ogasawara M; Nakashima M; Ichikawa M
Nihon Gan Chiryo Gakkai Shi; 1988 Jul; 23(7):1585-9. PubMed ID: 2846720
[No Abstract] [Full Text] [Related]
16. Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma.
Lo CM; Ngan H; Tso WK; Liu CL; Lam CM; Poon RT; Fan ST; Wong J
Hepatology; 2002 May; 35(5):1164-71. PubMed ID: 11981766
[TBL] [Abstract][Full Text] [Related]
17. Collagen chemoembolization: pharmacokinetics and tissue tolerance of cis-diamminedichloroplatinum(II) in porcine liver and rabbit kidney.
Daniels JR; Sternlicht M; Daniels AM
Cancer Res; 1988 May; 48(9):2446-50. PubMed ID: 3356008
[TBL] [Abstract][Full Text] [Related]
18. [Transarterial chemoembolization with high dose iodized oil for the treatment of large hepatocellular carcinoma].
Chen M; Li J; Zhang Y
Zhonghua Zhong Liu Za Zhi; 2001 Mar; 23(2):165-7. PubMed ID: 11783027
[TBL] [Abstract][Full Text] [Related]
19. Amifostine (Ethyol) as modulator of hepatic and biliary toxicity from intraarterial hepatic chemoembolization: results of a phase I study.
Fiorentini G; Giovanis P; Leoni M; De Giorgi U; Cariello A; Dazzi C; Caldeo A
Hepatogastroenterology; 2001; 48(38):313-6. PubMed ID: 11379297
[TBL] [Abstract][Full Text] [Related]
20. [Intra-hepatic artery infusional chemotherapy with cisplatin suspension in lipiodol (LPS) of hepatocellular carcinoma (I)--Preparation of LPS and its anticancer effect on a rabbit liver cancer model after injection into the hepatic artery].
Fukushima S; Kishimoto S; Hayashi Y; Kaneko M; Nakano M; Shibata J; Fujiyama S; Sato T
Nihon Gan Chiryo Gakkai Shi; 1988 Dec; 23(11):2743-9. PubMed ID: 2854837
[No Abstract] [Full Text] [Related]
[Next] [New Search]
